Iodure De Potassium Serb

Potassium Iodide, the active ingredient in Iodure De Potassium Serb, is a thyroid blocking agent presented as an oral preparation for oral use. It is employed to protect the thyroid gland from uptake of radioactive iodine in radiation emergencies.

GNH USA supplies Iodure De Potassium Serb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Potassium Iodide is used as a thyroid blocking agent to protect against radioactive iodine exposure.

- Radiation emergency prophylaxis: prevents thyroid uptake of radioactive iodine after nuclear incidents. - Thyroid protection: saturates the gland with stable iodide to reduce radiation‑induced damage. - Pre‑exposure prophylaxis: administered before anticipated exposure to minimize thyroid cancer risk.

Potassium Iodide may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Metallic or salty taste in the mouth. - Nausea or vomiting. - Abdominal discomfort or cramping. - Mild headache. - Diarrhea. - Skin flushing.

Serious or Rare Side Effects: - Allergic reaction including rash, itching, or anaphylaxis. - Severe thyroid dysfunction such as hyperthyroidism or hypothyroidism. - Iodide‑induced pulmonary edema (rare). - Persistent fever. - Acute kidney injury in susceptible individuals.

Potassium Iodide should be used with careful consideration of patient history and clinical context.

- Assess iodine status: verify baseline iodine intake before administration. - Avoid in known iodine allergy: discontinue if hypersensitivity occurs. - Use cautiously in thyroid disease: monitor patients with existing hyper‑ or hypothyroidism. - Monitor pregnant or lactating women: weigh potential benefits against fetal or infant risk. - Do not exceed prescribed amount: follow prescriber instructions precisely. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Potassium Iodide can affect the activity of several other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Levothyroxine: may reduce effectiveness of thyroid hormone replacement. - Antithyroid drugs (methimazole, propylthiouracil): can diminish iodine blocking action. - Radioactive iodine therapy: interferes with intended therapeutic uptake.

Moderate Interactions (Monitor Closely): - Diuretics: may alter iodide excretion and plasma levels. - ACE inhibitors: potential for altered renal handling of iodide. - NSAIDs: may increase risk of renal impairment when combined with high iodide doses.